126 related articles for article (PubMed ID: 10375117)
1. Expression of ras, c-myc, and p53 proteins in cervical intraepithelial neoplasia.
Marangoz S; Güllü IH
Cancer; 1999 Jun; 85(12):2668-9. PubMed ID: 10375117
[No Abstract] [Full Text] [Related]
2. ras and c-myc oncoproteins during tumor progression in the uterine cervix.
Nair SA; Nair MB; Jayaprakash PG; Rajalekshmy TN; Nair MK; Pillai MR
Tumori; 1998; 84(5):583-8. PubMed ID: 9862521
[TBL] [Abstract][Full Text] [Related]
3. Uterine cervical dysplasia and cancer: identification of c-myc status by quantitative polymerase chain reaction.
Aoyama C; Peters J; Senadheera S; Liu P; Shimada H
Diagn Mol Pathol; 1998 Dec; 7(6):324-30. PubMed ID: 10207671
[TBL] [Abstract][Full Text] [Related]
4. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
[TBL] [Abstract][Full Text] [Related]
5. Expression of ras, c-myc, and p53 proteins in cervical intraepithelial neoplasia.
Slagle BL; Kaufman RH; Reeves WC; Icenogle JP
Cancer; 1998 Oct; 83(7):1401-8. PubMed ID: 9762942
[TBL] [Abstract][Full Text] [Related]
6. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
[TBL] [Abstract][Full Text] [Related]
7. c-myc Gene Copy Number Variation in Cervical Exfoliated Cells Detected on Fluorescence in situ Hybridization for Cervical Cancer Screening.
Zhao WH; Hao M; Cheng XT; Yang X; Wang ZL; Cheng KY; Liu FL; Bai YX
Gynecol Obstet Invest; 2016; 81(5):416-23. PubMed ID: 26808725
[TBL] [Abstract][Full Text] [Related]
8. [Comparison and analysis of expression of c-myc and p16 in cervical carcinoma].
Ruan YH; Wei WL; Zhang HX; Liang ZN; Liu BY; Chen Y
Ai Zheng; 2003 Jun; 22(6):602-6. PubMed ID: 12948409
[TBL] [Abstract][Full Text] [Related]
9. [Importance of immunohistochemical studies in the diagnosis and the prognostic evaluation of cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix. Review].
García-Tamayo J; Molina J; Blasco-Olaetxea E
Invest Clin; 2009 Jun; 50(2):241-50. PubMed ID: 19662819
[TBL] [Abstract][Full Text] [Related]
10. Expression of p63, p53 and Ki-67 in Patients with Cervical Intraepithelial Neoplasia.
Mitildzans A; Arechvo A; Rezeberga D; Isajevs S
Turk Patoloji Derg; 2017; 33(1):9-16. PubMed ID: 28044307
[TBL] [Abstract][Full Text] [Related]
11. Genomic amplification patterns of human telomerase RNA gene and C-MYC in liquid-based cytological specimens used for the detection of high-grade cervical intraepithelial neoplasia.
Chen S; Yang Z; Zhang Y; Qiao Y; Cui B; Zhang Y; Kong B
Diagn Pathol; 2012 Apr; 7():40. PubMed ID: 22500694
[TBL] [Abstract][Full Text] [Related]
12. p53 and human papilloma virus type 16 in cervical intraepithelial neoplasia and carcinoma.
ter Harmsel B; van Belkum A; Quint W; Pronk A; Kuijpers J; Ramaekers F; Tandon A; Smedts F
Int J Gynecol Pathol; 1995 Apr; 14(2):125-33. PubMed ID: 8601524
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J
Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432
[TBL] [Abstract][Full Text] [Related]
14. c-myc gene amplification detected in preinvasive intraepithelial cervical lesions.
Golijow CD; Abba MC; Mourón SA; Gómez MA; Dulout FN
Int J Gynecol Cancer; 2001; 11(6):462-5. PubMed ID: 11906549
[TBL] [Abstract][Full Text] [Related]
15. FHIT and C-MYC expression in cervical histology and cytology as biomarkers for detecting high-grade intraepithelial neoplasia in human papillomavirus-positive women.
Yang F; Cui Z; Liao Y; Tian R; Fan W; Jin Z; Hu Z; Yao S
Cancer Biomark; 2020; 27(3):303-312. PubMed ID: 31771040
[TBL] [Abstract][Full Text] [Related]
16. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
[TBL] [Abstract][Full Text] [Related]
17. Cellular oncogenes and suppressor genes as prognostic markers in cancer.
Duffy MJ
Clin Biochem; 1993 Dec; 26(6):439-47. PubMed ID: 8124858
[TBL] [Abstract][Full Text] [Related]
18. Amplification and overexpression of TP63 and MYC as biomarkers for transition of cervical intraepithelial neoplasia to cervical cancer.
Zhu D; Jiang XH; Jiang YH; Ding WC; Zhang CL; Shen H; Wang XL; Ma D; Hu Z; Wang H
Int J Gynecol Cancer; 2014 May; 24(4):643-8. PubMed ID: 24662128
[TBL] [Abstract][Full Text] [Related]
19. Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis.
Weston A; Caporaso NE; Perrin LS; Sugimura H; Tamai S; Krontiris TG; Trump BF; Hoover RN; Harris CC
Environ Health Perspect; 1992 Nov; 98():61-7. PubMed ID: 1486864
[TBL] [Abstract][Full Text] [Related]
20. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
